Table 7: Choroid metastasis from well-differentiated thyroid cancer.
| Study | Age/sex | Primary tumor type | Other metastases |
| Ritland, et al. [71] | 80/F | FTC | Lung, mediastinal tumor, bone |
| Scott, et al. [72] | 50/M | FTC | Lung, bone |
| Slamovits, et al. [73] | 64/F | FTC | Right and left paratracheal lesion, bone, lung |
| Arat, et al. [74] | 83/M | FTC | Lung, bone, liver, skin (Widespread metastasis) |
| Seneviratne, et al. [75] | 74/F | FTC | Bone, lung, abdominal wall |
| Dutton, et al. [76] | 70/M | HCTC | Lung, right suprarenal metastasis |
| Biswas, et al. [77] | 37/M | Clear-cell TC | No data available |
| Avram, et al. [78] | 81/M | PTC | Neck recurrence, mediastinal LN, lung, bone, skin |
| Anteby, et al. [79] | 55/F | PTC | Mediastinal LN, lung |
| Ahmadi, et al. [80] | 43/F | PTC | Lung, bone, brain |
| Bucerius, et al. [81] | 61/F | PTC | Mediastinal LN, lung, malignant pleural effusion, skin |
| Tran, et al. [82] | 36/F | PTC | Multiple bone lesions, lung |
| Singh, et al. [83] | 70/M | PTC occult microcarcinoma | No other metastases were detected |
| Yunta, et al. [84] | 42/M | PTC (Tall-cell variant) | Bone, brain, skin |
| Søndergaard, et al. [85] | 29/F | MTC (MEN 2B) | Bone |
| Shields, et al. [86] | 36/F | MTC (MEN 2B) | Widespread metastases |
| Rosário, et al. [87] | 43/M | MTC (Sporadic) | Cervical and mediastinal LN, lung, liver, bone |
| Bianciotto, et al. [88] | 56/M | MTC (Sporadic) | Mass in the right upper eyelid, lung, cervical lymph node, liver |
| Yildiz, et al. [89] | 63/M | MTC (Sporadic) | Widespread metastases: Bone, liver, lung, lymph nodes |
| Palm, et al. [90] | 42/M | MTC (Sporadic) | Widespread metastases; mediastinal LN, lungs, bones, bilateral adrenals |
| Ozpacaci, et al. [91] | 76/M | Insular TC | Left cervical LN, massive bilateral lung metastases |
| Puri, et al. [92] | 46/M | Squamous TC | No data available |
FTC: Follicular thyroid carcinoma, LN: Lymph nodes, MTC: Medullary thyroid carcinoma, PTC: Papillary thyroid carcinoma, TC: Thyroid carcinoma